Insider Transactions in Q4 2023 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2023
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
24,158
-2.81%
|
-
|
|
Nov 13
2023
|
Kimberly Blackwell Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.92%
|
$50,000
$10.29 P/Share
|
|
Nov 10
2023
|
David Michael Johnson Director |
BUY
Open market or private purchase
|
Direct |
17,000
+10.53%
|
$153,000
$9.88 P/Share
|
|
Oct 04
2023
|
Carrie Brownstein Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,628
-4.63%
|
$201,932
$19.67 P/Share
|
|
Oct 04
2023
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,482
-0.7%
|
$104,158
$19.67 P/Share
|
|
Oct 04
2023
|
Kevin D. Bunker Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,068
-0.35%
|
$115,292
$19.67 P/Share
|